{"hands_on_practices": [{"introduction": "Before we can evaluate the cost-effectiveness of any health program, we must first understand how to accurately determine its cost. This foundational exercise breaks down the total cost of a hypothetical vaccination campaign into its fixed and variable components, allowing you to calculate the crucial metric of unit cost ([@problem_id:4975322]). Mastering this 'ingredients-based' approach is the essential first step in any economic evaluation.", "problem": "A Ministry of Health in a low-income country is planning a one-time outreach vaccination campaign. Using an ingredients-based costing approach, assume the provider perspective and a single budget period in which all costs are incurred and all doses are delivered. The program has a fixed overhead for planning, cold-chain rental, and supervision of $F$ United States dollars (USD) and a constant variable cost per dose of $v$ USD. The campaign is expected to deliver $N$ doses to beneficiaries. Assume no dose wastage and that variable costs scale linearly with doses delivered. Using only core definitions from cost analysis (that total economic cost is the sum of fixed and variable costs, and that the unit cost is the total cost divided by the number of doses delivered), compute the unit cost of a delivered dose for the campaign when $F = 10{,}000$ USD, $v = 3$ USD per dose, and $N = 5{,}000$ doses. Express your final answer in United States dollars per dose (USD per dose). Provide the exact value (no rounding required).", "solution": "The user has provided a problem from the field of global health economics. The first step, as per the established protocol, is to validate the problem statement.\n\n### Step 1: Extract Givens\n- **Perspective:** provider perspective\n- **Costing Approach:** ingredients-based costing\n- **Budget Period:** a single budget period\n- **Fixed Overhead Cost ($F$):** $10,000$ United States dollars (USD)\n- **Constant Variable Cost per Dose ($v$):** $3$ USD per dose\n- **Number of Doses Delivered ($N$):** $5,000$ doses\n- **Assumptions:**\n    - No dose wastage.\n    - Variable costs scale linearly with doses delivered.\n- **Definitions:**\n    - Total economic cost is the sum of fixed and variable costs.\n    - Unit cost is the total cost divided by the number of doses delivered.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the validation criteria.\n- **Scientifically Grounded:** The problem uses standard, fundamental definitions from microeconomics and health economic evaluation, specifically cost analysis. The concepts of fixed cost, variable cost, total cost, and average (unit) cost are well-established principles. The problem is a direct application of these principles.\n- **Well-Posed:** The problem statement is self-contained and provides all necessary data ($F$, $v$, $N$) and definitions to compute a single, unambiguous answer for the unit cost.\n- **Objective:** The language is technical, precise, and free of subjective or opinion-based claims. The values provided are numerically explicit.\n\nThe problem does not exhibit any of the enumerated flaws:\n1.  **Scientific or Factual Unsoundness:** It is based on correct economic principles.\n2.  **Non-Formalizable or Irrelevant:** It is perfectly formalizable into a mathematical equation and is directly relevant to the specified topic.\n3.  **Incomplete or Contradictory Setup:** The setup is complete and internally consistent.\n4.  **Unrealistic or Infeasible:** The cost and volume figures are plausible for a public health campaign in the specified context.\n5.  **Ill-Posed or Poorly Structured:** A unique, stable solution exists. All terms are clearly defined.\n6.  **Pseudo-Profound, Trivial, or Tautological:** The problem, while elementary, serves as a valid test of understanding of core cost analysis definitions. It is not trivial or tautological.\n7.  **Outside Scientific Verifiability:** The result is arithmetically verifiable.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution will be derived.\n\n### Solution Derivation\nThe problem requires the calculation of the unit cost of a delivered vaccine dose. The solution proceeds by applying the definitions provided in the problem statement.\n\nLet $C_{T}$ represent the total economic cost of the campaign. According to the problem's definition, the total cost is the sum of fixed and variable costs.\nLet $C_{F}$ be the total fixed cost and $C_{V}$ be the total variable cost.\n$$C_{T} = C_{F} + C_{V}$$\n\nThe fixed overhead cost, $F$, is given as $10,000$ USD. This cost does not change with the number of doses delivered. Therefore,\n$$C_{F} = F = \\$10,000$$\n\nThe variable cost per dose, $v$, is given as $3$ USD. The problem states that variable costs scale linearly with the number of doses delivered, $N$. The total variable cost, $C_V$, is the product of the variable cost per dose and the total number of doses.\n$$C_{V} = v \\times N$$\nWith $v = 3$ USD/dose and $N = 5,000$ doses, the total variable cost is:\n$$C_{V} = \\$3 \\times 5,000 = \\$15,000$$\n\nNow, the total economic cost, $C_{T}$, can be calculated:\n$$C_{T} = C_{F} + C_{V} = \\$10,000 + \\$15,000 = \\$25,000$$\n\nThe problem asks for the unit cost, which we will denote as $U$. The unit cost is defined as the total cost divided by the number of doses delivered.\n$$U = \\frac{C_{T}}{N}$$\n\nSubstituting the calculated total cost and the given number of doses:\n$$U = \\frac{\\$25,000}{5,000 \\text{ doses}}$$\n$$U = 5 \\text{ USD per dose}$$\n\nAlternatively, we can first derive a general symbolic expression for the unit cost, $U$.\n$$U = \\frac{C_{T}}{N} = \\frac{C_{F} + C_{V}}{N} = \\frac{F + v \\times N}{N}$$\nThis expression can be separated into two terms:\n$$U = \\frac{F}{N} + \\frac{v \\times N}{N} = \\frac{F}{N} + v$$\nThis final symbolic expression represents the unit cost as the sum of the average fixed cost (total fixed cost spread over all units) and the variable cost per unit.\n\nSubstituting the given values into this symbolic expression:\n- $F = 10,000$\n- $v = 3$\n- $N = 5,000$\n\n$$U = \\frac{10,000}{5,000} + 3$$\n$$U = 2 + 3$$\n$$U = 5$$\nThe final answer is $5$ USD per dose. The result is consistent across both calculation methods. The problem requires an exact value, which is $5$.", "answer": "$$\\boxed{5}$$", "id": "4975322"}, {"introduction": "Often, public health decisions are not about a single program, but a choice between alternatives. This practice introduces the Incremental Cost-Effectiveness Ratio (ICER), a core tool for comparing a new, more effective, but costlier intervention against a standard one ([@problem_id:4975325]). By calculating the 'cost per additional unit of health gained,' you will learn to apply a willingness-to-pay threshold to make a rational, evidence-based decision.", "problem": "A public health agency in a lower-middle-income country is evaluating two alternative first-line treatments for a prevalent chronic infectious disease. From the health system perspective and using a lifetime horizon, both costs and health outcomes have been appropriately discounted to the present. Treatment A has a per-patient cost of $\\$1{,}500$ and yields $1.8$ quality-adjusted life years (QALYs), and Treatment B has a per-patient cost of $\\$1{,}000$ and yields $1.2$ QALYs. The agency intends to decide based on the incremental cost-effectiveness ratio (ICER), defined conceptually as the additional cost per additional unit of health gained when moving from a comparator to an alternative, and a willingness-to-pay threshold of $\\lambda=\\$1{,}000$ per QALY. Quality-Adjusted Life Year (QALY) is defined as a measure of health benefit that weights each year of life by a health-related quality of life factor on the interval $[0,1]$. The decision rule is grounded in the principle that an intervention is deemed cost-effective if the additional cost per additional unit of health gained does not exceed the decision-makerâ€™s willingness-to-pay threshold.\n\nUsing only the fundamental definitions of incremental cost, incremental effect, ICER, and the threshold-based decision rule, compute the incremental cost-effectiveness ratio of Treatment A versus Treatment B and determine whether Treatment A is cost-effective relative to Treatment B at $\\lambda=\\$1{,}000$ per QALY. Report the ICER in United States dollars per quality-adjusted life year (USD/QALY) and round your ICER to four significant figures.", "solution": "The problem statement is evaluated to be scientifically grounded, well-posed, and objective. It provides a complete and consistent set of data and definitions from the field of health economic evaluation, specifically cost-effectiveness analysis. The problem is valid and permits a formal solution.\n\nThe task is to compute the incremental cost-effectiveness ratio (ICER) of Treatment A versus Treatment B and to determine if Treatment A is cost-effective relative to Treatment B based on a given willingness-to-pay threshold.\n\nFirst, we identify and define the given parameters:\n- Cost of Treatment A, $C_A = \\$1,500$.\n- Effectiveness of Treatment A, $E_A = 1.8$ quality-adjusted life years (QALYs).\n- Cost of Treatment B, $C_B = \\$1,000$.\n- Effectiveness of Treatment B, $E_B = 1.2$ QALYs.\n- The willingness-to-pay threshold, $\\lambda = \\$1,000$ per QALY.\n\nThe problem asks for an evaluation of \"Treatment A versus Treatment B\". In cost-effectiveness analysis, this implies that Treatment B is the comparator (or baseline) and Treatment A is the new alternative intervention being evaluated. This is the standard convention, particularly when the alternative is more costly and more effective, i.e., $C_A > C_B$ and $E_A > E_B$. The analysis seeks to determine if the additional health gain from Treatment A justifies its additional cost.\n\nThe ICER is defined as the ratio of the incremental cost to the incremental effectiveness.\n\nThe incremental cost, denoted as $\\Delta C$, is the difference between the cost of the alternative (Treatment A) and the cost of the comparator (Treatment B).\n$$\n\\Delta C = C_A - C_B\n$$\nSubstituting the given values:\n$$\n\\Delta C = \\$1,500 - \\$1,000 = \\$500\n$$\n\nThe incremental effect, denoted as $\\Delta E$, is the difference between the effectiveness of the alternative (Treatment A) and the effectiveness of the comparator (Treatment B).\n$$\n\\Delta E = E_A - E_B\n$$\nSubstituting the given values:\n$$\n\\Delta E = 1.8 \\text{ QALYs} - 1.2 \\text{ QALYs} = 0.6 \\text{ QALYs}\n$$\n\nNow, we can compute the ICER using its definition:\n$$\nICER = \\frac{\\Delta C}{\\Delta E}\n$$\nSubstituting the calculated incremental values:\n$$\nICER = \\frac{\\$500}{0.6 \\text{ QALYs}} = \\frac{500}{0.6} \\frac{\\text{USD}}{\\text{QALY}} = \\frac{5000}{6} \\frac{\\text{USD}}{\\text{QALY}} = \\frac{2500}{3} \\frac{\\text{USD}}{\\text{QALY}}\n$$\nAs a decimal, the exact value is $833.333...$ USD/QALY. The problem requires rounding this value to four significant figures. The first four significant digits are $8$, $3$, $3$, $3$. The fifth digit is $3$, which is less than $5$, so we do not round up the fourth digit.\n$$\nICER \\approx 833.3 \\frac{\\text{USD}}{\\text{QALY}}\n$$\n\nThe final step is to apply the decision rule. The rule states that an intervention is cost-effective if its ICER does not exceed the willingness-to-pay threshold, $\\lambda$. Mathematically, Treatment A is cost-effective relative to Treatment B if:\n$$\nICER \\le \\lambda\n$$\nSubstituting the calculated ICER and the given threshold $\\lambda$:\n$$\n\\frac{2500}{3} \\frac{\\text{USD}}{\\text{QALY}} \\le \\$1,000 \\frac{\\text{USD}}{\\text{QALY}}\n$$\n$$\n833.333... \\le 1000\n$$\nThis inequality is true.\n\nTherefore, because the incremental cost-effectiveness ratio of Treatment A compared to Treatment B is less than the specified willingness-to-pay threshold, Treatment A is considered cost-effective. The ICER, rounded to four significant figures, is $833.3$ USD/QALY.", "answer": "$$\n\\boxed{833.3}\n$$", "id": "4975325"}, {"introduction": "The costs and health benefits of an intervention rarely occur all at once; they unfold over time. This exercise tackles the critical concept of discounting, which accounts for the time value of money and health, reflecting the principle that future benefits and costs are worth less than present ones ([@problem_id:4975363]). You will practice calculating the present value of both costs and health outcomes over a multi-year period, a skill essential for evaluating any long-term health program.", "problem": "A public health program in a low-middle-income country is evaluating a new chronic therapy that improves health-related quality of life and incurs annual programmatic costs. Assume the annual health effects and costs accrue at the end of each year for a fixed horizon and are discounted using standard economic evaluation practice in global health. The therapy yields a constant flow of $0.5$ Quality-Adjusted Life Years (QALYs) per year for $4$ years. The annual programmatic cost is $400$ United States dollars (USD) per year for the same $4$ years. The health effects are discounted at an effects discount rate $r_{e}=0.03$ per year, and the costs are discounted at a cost discount rate $r_{c}=0.05$ per year. \n\nUsing the principle that the present value of a future flow received at the end of year $t$ is the flow divided by $(1+r)^{t}$, compute:\n- The total discounted QALYs over $4$ years.\n- The total discounted costs over $4$ years.\n\nExpress the discounted QALYs in QALYs and the discounted costs in USD. Round each result to four significant figures. Provide the final numerical answers only; do not include intermediate steps in the final answers. If you need to present multiple values, write them as a single row vector.", "solution": "The problem statement is evaluated and found to be valid. It is a well-posed problem grounded in the standard principles of economic evaluation and cost-effectiveness analysis in public health. All necessary data and definitions are provided, the parameters are scientifically realistic, and the objectives are clear and formalizable.\n\nThe task is to compute the total discounted Quality-Adjusted Life Years (QALYs) and total discounted costs over a specified time horizon. The problem states that a future flow received at the end of year $t$ has a present value (PV) equal to the flow divided by $(1+r)^t$, where $r$ is the discount rate.\n\nThe total present value of a stream of constant annual flows $A$ occurring at the end of each year for $T$ years is given by the sum:\n$$ \\text{PV} = \\sum_{t=1}^{T} \\frac{A}{(1+r)^t} $$\nThis is a finite geometric series with first term $a = \\frac{A}{1+r}$ and common ratio $q = \\frac{1}{1+r}$. The sum can be calculated using the closed-form formula for the present value of an ordinary annuity:\n$$ \\text{PV} = A \\left( \\frac{1 - (1+r)^{-T}}{r} \\right) $$\n\nFirst, we compute the total discounted QALYs.\nThe given parameters are:\nAnnual QALYs, $Q = 0.5$.\nTime horizon, $T = 4$ years.\nEffects discount rate, $r_{e} = 0.03$.\n\nThe total discounted QALYs, denoted as $DQALYs$, is calculated as:\n$$ DQALYs = \\sum_{t=1}^{4} \\frac{Q}{(1+r_e)^t} = \\sum_{t=1}^{4} \\frac{0.5}{(1+0.03)^t} $$\nUsing the annuity formula:\n$$ DQALYs = Q \\left( \\frac{1 - (1+r_e)^{-T}}{r_e} \\right) = 0.5 \\left( \\frac{1 - (1+0.03)^{-4}}{0.03} \\right) $$\n$$ DQALYs = 0.5 \\left( \\frac{1 - (1.03)^{-4}}{0.03} \\right) $$\nWe calculate the value of $(1.03)^{-4}$:\n$$ (1.03)^{-4} \\approx 0.888487045 $$\nSubstituting this value back into the equation:\n$$ DQALYs \\approx 0.5 \\left( \\frac{1 - 0.888487045}{0.03} \\right) = 0.5 \\left( \\frac{0.111512955}{0.03} \\right) \\approx 0.5(3.7170985) \\approx 1.85854925 $$\nRounding to four significant figures, the total discounted QALYs are $1.859$.\n\nNext, we compute the total discounted costs.\nThe given parameters are:\nAnnual cost, $C = 400$ USD.\nTime horizon, $T = 4$ years.\nCosts discount rate, $r_{c} = 0.05$.\n\nThe total discounted costs, denoted as $DCosts$, is calculated as:\n$$ DCosts = \\sum_{t=1}^{4} \\frac{C}{(1+r_c)^t} = \\sum_{t=1}^{4} \\frac{400}{(1+0.05)^t} $$\nUsing the annuity formula:\n$$ DCosts = C \\left( \\frac{1 - (1+r_c)^{-T}}{r_c} \\right) = 400 \\left( \\frac{1 - (1+0.05)^{-4}}{0.05} \\right) $$\n$$ DCosts = 400 \\left( \\frac{1 - (1.05)^{-4}}{0.05} \\right) $$\nWe calculate the value of $(1.05)^{-4}$:\n$$ (1.05)^{-4} \\approx 0.82270247 $$\nSubstituting this value back into the equation:\n$$ DCosts \\approx 400 \\left( \\frac{1 - 0.82270247}{0.05} \\right) = 400 \\left( \\frac{0.17729753}{0.05} \\right) \\approx 400(3.5459506) \\approx 1418.38024 $$\nRounding to four significant figures, the total discounted cost is $1418$ USD.\n\nThe two requested values are the total discounted QALYs and the total discounted costs.", "answer": "$$\\boxed{\\begin{pmatrix} 1.859 & 1418 \\end{pmatrix}}$$", "id": "4975363"}]}